Background
Traditional middle and lower facelifts are not suitable for patients with mild skin laxity or who wish to avoid incision scars.
Objective
We present the stab access fascia suspension lift (SAFS‐lift) technique, which does not require regular skin incisions, as a reliable surgical facelift strategy for the lower and middle face.
Methods
From September 2020 to September 2021, 38 patients underwent SAFS‐lift. SAFS‐lift involved (1) incomplete subcutaneous undermining with hydrodissection‐assisted tunneling; (2) complete subcutaneous undermining with a dissecting cannula in the zygomatic buccal groove area and hollow below zygomatic arch; and (3) maximal firm superficial musculoaponeurotic system suspension with polydioxanone barbed threads in loops. All patients evaluated the outcome according to the Global Aesthetic Improvement Scale. Four plastic surgeons evaluated postsurgery result with a five‐point Likert scale (5 = excellent, 4 = good, 3 = fair, 2 = no change, and 1 = worse).
Results
Thirty‐six patients were successfully enrolled. The mean follow‐up period was 14.72 ± 3.89 months. No patients showed visible scarring 6 months after surgery. The minor complication rate was 19.4%. They all subsided within 1–6 weeks without treatment. No infection, hematoma, seroma, or facial nerve injury was observed. Patients’ outcome ratings were 4.22 ± 0.58 (3 months), 4.69 ± 0.46 (6 months), and 4.69 ± 0.54 (1 year). Surgeons' outcome scoring was 3.98 ± 0.95.
Conclusions
Stab access fascia suspension‐lift is a predictable, effective, and safe facelift technique that can be performed without making noticeable incisions and resecting the skin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.